Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)
GRACE and CCO Partnership - Information for a Diagnosis of Advanced NSCLC
dbrock
Immunotherapy for Advanced NSCLC - Discussing Goals and Treatments with Your Health Care Provider
Image
In partnership with Clinical Care Options, GRACE Founder and President H. Jack West, MD provides this informational video regarding immunotherapy for advanced NSCLC and discussing goals and treatments with your health care providers. We invite you to watch and join the conversation.
For those dealing with questions regarding immune checkpoint inhibitor therapy, we have developed another helpful downloadable pdf for patients, Understanding the Current Landscape of Immune Checkpoint Inhibitor Therapy in Advanced NSCLC: A Resource for Patients.
Also in partnership with Clinical Care Options, we have developed a helpful interactive online tool to help you understand more about your disease and treatment options.
Did you recently receive a diagnosis of non small cell lung cancer?
GRACE has partnered with Clinical Care Options to develop an interactive online tool to help you understand more about your disease and treatment options. The goal of this tool is to help you better understand your diagnosis of locally advanced or metastatic NSCLC, to better understand your treatment options, and to become partners with the oncology team instead of being a bystander in your cancer care. A series of questions developed by the experts allow you to select information about yourself and your cancer that are necessary to consider when making treatment choices in advanced NSCLC.
Answer a series of multiple-choice questions and then get treatment options chosen by the 5 lung cancer experts listed below.
- David R. Gandara, MD, UC Davis Health
- Melissa L. Johnson, MD, Sarah Cannon
- Suresh S. Ramalingam, MD, Emory Winship Cancer Institute
- Heather Wakelee, MD, Stanford University
- H. Jack West, MD, City of Hope
To assist you in gathering information click here to download a PDF consultation checklist with useful questions for your oncologist about your advanced NSCLC disease. For additional tips please see "How to Talk to Your Oncologist". If you are a health care provider, you can find CCO's clinician-focused tool here: https://www.clinicaloptions.com/oncology/programs/nsclc-clinical-insights/interactive-decision-support-tool/nsclc_tool_2018/page-1?origin=2.
Please join the conversation! We would love to hear from you!
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Image
Video
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended.
¡Los vídeos están disponibles BAJO DEMANDA!
Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas.
Image
Article
Da click aquí para más información y para registrarte ahora
Online Community
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.